| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Hemolysis | D006461 | 131 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Hypercholesterolemia | D006937 | 91 associated lipids |
(e,e,e,e)-squalene
(e,e,e,e)-squalene is a lipid of Fatty Acyls (FA) class. (e,e,e,e)-squalene is associated with abnormalities such as Hypercholesterolemia and Cataract. The involved functions are known as Process, metaplastic cell transformation, Protein Overexpression, Anabolism and Biosynthetic Pathways. (e,e,e,e)-squalene often locates in Membrane, Protoplasm, Plasma membrane, Tissue membrane and Back. The associated genes with (e,e,e,e)-squalene are Genome, IMPACT gene, GAPDH gene, GTF2I gene and Chromatin. The related lipids are Membrane Lipids, cycloartenol, Sterols, Fatty Acids and Nonesterified Fatty Acids.
Cross Reference
Introduction
To understand associated biological information of (e,e,e,e)-squalene, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with (e,e,e,e)-squalene?
(e,e,e,e)-squalene is suspected in Hypercholesterolemia, Cataract and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with (e,e,e,e)-squalene
PubChem Associated disorders and diseases
What pathways are associated with (e,e,e,e)-squalene
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with (e,e,e,e)-squalene?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with (e,e,e,e)-squalene?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with (e,e,e,e)-squalene?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with (e,e,e,e)-squalene?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with (e,e,e,e)-squalene?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with (e,e,e,e)-squalene
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Nakagawa M et al. | Potentiation by squalene of the cytotoxicity of anticancer agents against cultured mammalian cells and murine tumor. | 1985 | Jpn. J. Cancer Res. | pmid:2408954 |
| Yamaguchi T et al. | Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system. | 1985 | Jpn. J. Cancer Res. | pmid:3935620 |
| Hwang SM et al. | Comparison of the adverse events associated with MF59-adjuvanted and non-adjuvanted H1N1 vaccines in healthy young male Korean soldiers. | 2012 | Jpn. J. Infect. Dis. | pmid:22627298 |
| Suzuki R | Specific requirements of bile salts for absorption of cholesterol from the intestine. | 1968 | Keio J Med | pmid:5715537 |
| SCHOEN H and FAHSOLD W | [Studies on the problem of resorption of squalene]. | 1960 | Klin. Wochenschr. | pmid:14443328 |
| Murakami S | Isolation and analysis of squalene alcohols from rat preputial glands. | 1973 | Kobe J Med Sci | pmid:4764042 |
| Houston L et al. | Response of guinea pigs to a vaccine containing a new adjuvant (SAF) and gram-negative bacteria. | 1995 | Lab. Anim. Sci. | pmid:7752616 |
| Robuccio JA et al. | Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs. | 1995 | Lab. Anim. Sci. | pmid:7474883 |
| Budiarso IT | Fish oil versus olive oil. | 1990 | Lancet | pmid:1978131 |
| Rickman LS et al. | Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine. | 1991 | Lancet | pmid:1673211 |
| Nicholson KG et al. | Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. | 2001 | Lancet | pmid:11425416 |
| Griffiths PD et al. | Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. | 2011 | Lancet | pmid:21481708 |
| McElhaney JE et al. | AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial. | 2013 | Lancet Infect Dis | pmid:23518156 |
| Ledgerwood JE | AS03-adjuvanted influenza vaccine in elderly people. | 2013 | Lancet Infect Dis | pmid:23518157 |
| Ambike A et al. | Interaction of self-assembled squalenoyl gemcitabine nanoparticles with phospholipid-cholesterol monolayers mimicking a biomembrane. | 2011 | Langmuir | pmid:21413743 |
| Shrestha LK et al. | Effect of water on foaming properties of diglycerol fatty acid ester-oil systems. | 2007 | Langmuir | pmid:17523681 |
| Arias JL et al. | Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting. | 2008 | Langmuir | pmid:18540685 |
| Gilmore SF et al. | Role of squalene in the organization of monolayers derived from lipid extracts of Halobacterium salinarum. | 2013 | Langmuir | pmid:23713788 |
| Rasch MR et al. | Chains, sheets, and droplets: assemblies of hydrophobic gold nanocrystals with saturated phosphatidylcholine lipid and squalene. | 2012 | Langmuir | pmid:23033891 |
| Lepeltier E et al. | Self-assembly of squalene-based nucleolipids: relating the chemical structure of the bioconjugates to the architecture of the nanoparticles. | 2013 | Langmuir | pmid:24219056 |
| Scallen TJ et al. | Sterol carrier protein hypothesis: requirement for three substrate-specific soluble proteins in liver cholesterol biosynthesis. | 1975 | Life Sci. | pmid:165341 |
| Miettinen TA | Serum squalene and methyl sterols as indicators of cholesterol synthesis in vivo. | 1969 | Life Sci. | pmid:5801489 |
| Foti L et al. | Biosynthesis of cholesterol from long-chain fatty acids in cell-free systems from rat liver. | 1969 | Life Sci. | pmid:5804653 |
| Jones JP et al. | Lipid biosynthesis in neuron-enriched and glial-enriched fractions of rat brain: sterol formation. | 1971 | Life Sci. II | pmid:5569686 |
| Egwim PO and Kummerow FA | In vitro hepatic cholesterogenesis in rats fed corn oil and fat-free diets. | 1973 | Life Sci. II | pmid:4708203 |
| Mercer EI | Sterol biosynthesis inhibitors: their current status and modes of action. | 1991 | Lipids | pmid:1779706 |
| Yeo HC and Shibamoto T | Formation of formaldehyde and malonaldehyde by photooxidation of squalene. | 1992 | Lipids | pmid:1608304 |
| Cattel L et al. | The squalene-2,3-epoxide cyclase as a model for the development of new drugs. | 1986 | Lipids | pmid:3515096 |
| Kushwaha SC and Kates M | Lipid composition of Neurospora crassa. | 1976 | Lipids | pmid:136584 |
| Bell FP | Inhibition of hepatic sterol and squalene biosynthesis in rats fed di-i-ethylhexyl phthalate. | 1976 | Lipids | pmid:994746 |
| Johnson RC and Shah SN | Binding of squalene, lanosterol, desmosterol, and cholesterol to proteins in brain and liver 105,000 g supernatant fractions: evidence for specific binding sites. | 1976 | Lipids | pmid:994754 |
| Lutsky BN et al. | In vitro incorporation of 14C-acetate into lipids of hamster flank organ (costovertebral organ) sebaceous glands and epidermis. | 1974 | Lipids | pmid:4810504 |
| Brooks CJ et al. | Lipids of human atheroma. VI. Hydrocarbons of the atheromatous plaque. | 1970 | Lipids | pmid:5488810 |
| Ramsey RB et al. | The biosynthesis of cholesterol and other sterols by brain tissue. I. Subcellular biosynthesis in vitro. | 1971 | Lipids | pmid:5574907 |
| Cherayil GD et al. | Abnormal lipid composition of fat tissue in human mesenteric panniculitis. | 1981 | Lipids | pmid:6163941 |
| Nes WR | Role of sterols in membranes. | 1974 | Lipids | pmid:4607429 |
| Lees ND et al. | Cloning of the late genes in the ergosterol biosynthetic pathway of Saccharomyces cerevisiae--a review. | 1995 | Lipids | pmid:7791529 |
| Abe I and Prestwich GD | Identification of the active site of vertebrate oxidosqualene cyclase. | 1995 | Lipids | pmid:7791531 |
| Tilvis RS and Miettinen TA | Dietary squalene increases tissue sterols and fecal bile acids in the rat. | 1983 | Lipids | pmid:6835033 |
| Tilvis RS and Miettinen TA | Absorption and metabolic fate of dietary 3H-squalene in the rat. | 1983 | Lipids | pmid:6855483 |
| Strandberg TE | Sterol synthesis from biliary squalene in the jejunal mucosa of the rat in vivo. | 1983 | Lipids | pmid:6621260 |
| Balliano G et al. | 3-Carboxy-4-nitrophenyl-dithio-1,1',2-trisnorsqualene: a site-directed inactivator of yeast oxidosqualene cyclase. | 1993 | Lipids | pmid:8246689 |
| Ceruti M et al. | Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases. | 2001 | Lipids | pmid:11485168 |
| Viola F et al. | Rationally designed inhibitors as tools for comparing the mechanism of squalene-hopene cyclase with oxidosqualene cyclase. | 2000 | Lipids | pmid:10783007 |
| Matthan NR et al. | Deuterium uptake and plasma cholesterol precursor levels correspond as methods for measurement of endogenous cholesterol synthesis in hypercholesterolemic women. | 2000 | Lipids | pmid:11026626 |
| Nakagawa K et al. | gamma-Tocotrienol reduces squalene hydroperoxide-induced inflammatory responses in HaCaT keratinocytes. | 2010 | Lipids | pmid:20714817 |
| Lau HL et al. | Simultaneous quantification of free fatty acids, free sterols, squalene, and acylglycerol molecular species in palm oil by high-temperature gas chromatography--flame ionization detection. | 2005 | Lipids | pmid:16094863 |
| Choo YM et al. | Application of supercritical fluid chromatography in the quantitative analysis of minor components (carotenes, vitamin E, sterols, and squalene) from palm oil. | 2005 | Lipids | pmid:16028723 |
| Oliaro-Bosso S et al. | Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae. | 2005 | Lipids | pmid:16477810 |
| Borchman D et al. | Confirmation of the presence of squalene in human eyelid lipid by heteronuclear single quantum correlation spectroscopy. | 2013 | Lipids | pmid:24081494 |